Quarterly report · Q2
7776.TEDINET S100RMQI
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥67m | 2023-01-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥126m | 2022-01-01 → 2022-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥75m | 2022-01-01 → 2022-06-30 | Standalone | Net sales |
| Operating income | −¥359m | 2023-01-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | −¥349m | 2022-01-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | −¥367m | 2023-01-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥353m | 2022-01-01 → 2022-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥363m | 2023-01-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥355m | 2022-01-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | −¥364m | 2023-01-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | −¥760m | 2022-01-01 → 2022-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥357m | 2022-01-01 → 2022-06-30 | Standalone | Profit loss |
| Total assets | ¥2.0bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.7bn | at 2022-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥363m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥366m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.7bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥847m | at 2021-12-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥348m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥718m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥269m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥18m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥62m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥848m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥882m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥606m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-13.29 | 2023-01-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.49 | 2023-04-01 → 2023-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.54 | 2022-01-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.75 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.1% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 28,385,419 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 22,159,419 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥96m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥236m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥62m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥62m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥28m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥67m |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥67m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | −¥263m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥100m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥208m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥70m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥70m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥41m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥75m |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥75m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥248m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 443
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)岡野 光夫 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)千葉県市川市 | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)楽天証券株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区南青山２丁目６番２１号 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)矢野 鉦三 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)大阪府高槻市 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式 | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社セルシード | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都江東区青海二丁目５番10号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly financial statements (text) | CurrentQuarterDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes equity in earnings losses of affiliates if equity method is applied quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |